Skip to content.
|
Skip to navigation
Site Map
Accessibility
Contact
Search Site
only in current section
Advanced Search…
Sections
Home
The Context
Children Medicines
Facts about children medicines
European pediatric regulation
Existing Guidelines
Acute Lymphoblastic Leukemia
History of the disease
Past treatments
History of 6-Mercaptopurine (6MP)
History of Methotrexate (MTX)
Existing Treatments
Induction
Consolidation
Maintenance
Loulla & Philla
Origin of the Loulla&Philla project
Profile of the Loulla&Philla project
Structure of the Loulla&Philla programme
Future treatments: Loulla&Philla
The Consortium
ONLY FOR CHILDREN PHARMACEUTICALS
LABORATOIRE PHILIPPE DAVIOUD
CARDINAL SYSTEMS
FRANCE EUROPE INNOVATION
ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS
COPENHAGEN UNIVERSITY HOSPITAL
HEINRICH-HEINE-UNIVERSITÄT DÜSSELDORF
PHARMAFLOW
HOSPICES CIVILS DE LYON
CHRISTIAN-ALBRECHTS-UNIVERSITAET ZU KIEL
CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES
CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE
Newsletter
Newsletter
Subscribe to the Newsletter
Intranet
Navigation
Children Medicines
Acute Lymphoblastic Leukemia
Existing Treatments
Induction
Consolidation
Maintenance
Log in
Login Name
Password
Cookies are not enabled. You must enable cookies before you can log in.
Forgot your password?
You are here:
Home
→
The Context
→
Existing Treatments
Info
Existing Treatments
Induction
Consolidation
Maintenance
Document Actions
Send this
Print this
«
February 2012
»
February
Mo
Tu
We
Th
Fr
Sa
Su
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
Children Medicines
Facts about children medicines
Newsletter
Subscribe to the Newsletter